This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Ian Wilson, D.Phil
Hansen Professor of Structural Biology at The Scripps Research Institute


Dr. Wilson obtained his B.Sc. in Biochemistry from Edinburgh University (1971), D. Phil. (1976) and D.Sc. (2000) in Molecular Biophysics from Oxford University. He was a postdoctoral fellow at Harvard University (1977-1982). He joined The Scripps Research Institute as a faculty member in 1982, where he is currently Hansen Professor of Structural Biology and Chair of the Department of Integrative Structural and Computational Biology at Scripps Research. His laboratory focuses on the structural basis of immune recognition of microbial pathogens. His current focus is on how SARS-CoV-2, influenza virus, HIV-1, HCV and P. falciparum are recognized by broadly neutralizing and protective antibodies to inform on design of novel vaccines and therapeutics. From 2000–2016, Dr. Wilson directed the Joint Center for Structural Genomics (JCSG), a multi-institutional consortium that pioneered high-throughput structural methods and deposited 1600 novel structures in the Protein Data Bank. Dr. Wilson is a Fellow of the Royal Society, Corresponding Fellow of the Royal Society of Edinburgh, Member of the American Academy of Arts and Sciences, International Member of the National Academy of Sciences, Fellow of the American Academy of Microbiology, and an Honorary Fellow of Corpus Christi College, Oxford. He has authored more than 850 papers, and is on the Statistical Board of Reviewing Editors of Science and Editorial Board of Immunity.

Agenda Sessions

  • Structural Insights on Antigenic Variation of SARS-CoV-2 Spike for Antibody Recognition